BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 716006)

  • 1. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparisons of six artificial liver support regimes in fulminant hepatic coma rats.
    Tabata Y; Chang TM
    Trans Am Soc Artif Intern Organs; 1980; 26():394-9. PubMed ID: 7245521
    [No Abstract]   [Full Text] [Related]  

  • 3. Artificial liver: the effect of ACAC microencapsulated charcoal hemoperfusion on fulminant hepatic failure.
    Chirito E; Reiter B; Lister C; Chang TM
    Artif Organs; 1977 Aug; 1(1):76-83. PubMed ID: 616275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of possible toxins in hepatic coma including the removal of mercaptan by albumin-collodion charcoal.
    Chang TM; Lister C
    Int J Artif Organs; 1980 Mar; 3(2):108-12. PubMed ID: 7364505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemoperfusion through activated carbon adsorbents in liver failure and hepatic coma.
    Bartels O
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):324-9. PubMed ID: 696211
    [No Abstract]   [Full Text] [Related]  

  • 6. Acute fulminant hepatic failure. Potential therapeutic role of hemoperfusion.
    Willson RA
    Gastroenterology; 1975 Jul; 69(1):244-8. PubMed ID: 1097291
    [No Abstract]   [Full Text] [Related]  

  • 7. [Achievements in the treatment of acute hepatic insufficiency].
    Kozakiewicz H
    Pol Tyg Lek; 1981 Apr; 36(15):537-9. PubMed ID: 7024943
    [No Abstract]   [Full Text] [Related]  

  • 8. Hemoperfusion in 1981.
    Chang TM
    Contrib Nephrol; 1982; 29():11-22. PubMed ID: 7042197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experiences in the treatment of fulminant hepatic failure by conservative therapy, charcoal haemoperfusion, and polyacrylonitrile haemodialysis.
    Silk DB; Williams R
    Int J Artif Organs; 1978 Jan; 1(1):29-33. PubMed ID: 669832
    [No Abstract]   [Full Text] [Related]  

  • 10. Soluble liver extract as supplement to detoxification by hemoperfusion in liver failure.
    Dixit V; Chang TM
    Int J Artif Organs; 1981 Nov; 4(6):291-4. PubMed ID: 7333688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of parenchymatous hepatic coma using exchange transfusions].
    Kettner W; Hörning I; Strähnz K; Müller D; Oehme G; Fischer G
    Z Arztl Fortbild (Jena); 1971 Sep; 65(18):963-6. PubMed ID: 5151130
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of hemoperfusion using coated charcoal or tyrosinase artificial cells on middle molecules and tyrosine in brain and serum of hepatic coma rats.
    Shi ZQ; Chang TM
    Trans Am Soc Artif Intern Organs; 1982; 28():205-9. PubMed ID: 6819667
    [No Abstract]   [Full Text] [Related]  

  • 13. A combined charcoal-resin hemoperfusion system in acute experimental hepatic failure in pigs. Depurative activity on plasma amino acids.
    Marrano D; Plicchi G; Liguori L; Marchesini G; Campione O; Spighi M; Roversi CA; Betti V; Vatrella S; Melli A
    Life Support Syst; 1983; 1 Suppl 1():74-7. PubMed ID: 6336465
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hemoperfusion across charcoal in acute hepatic failure in the dog].
    Horák J; Horký J; Rábl M
    Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982
    [No Abstract]   [Full Text] [Related]  

  • 15. Experimental artificial liver support with emphasis on fulminant hepatic failure: concepts and review.
    Chang TM
    Semin Liver Dis; 1986 May; 6(2):148-58. PubMed ID: 3529408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical, hematological and histological changes in a fulminant hepatic failure rat model for artificial liver assessment.
    Chirito E; Lister C; Chang TM
    Artif Organs; 1979 Feb; 3(1):42-6. PubMed ID: 435123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs.
    Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of hemoperfusion using polyetherurethane sheet embedded with powdered charcoal (UPC) on middle molecules of hepatic failure dogs.
    Kawanishi H; Nishiki M; Kanao M; Nakagawa K; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Dec; 33(4):633-8. PubMed ID: 6534919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Variation of serum free amino acids in fulminant hepatitis treated with hepatic assists (author's transl)].
    Tsuji Y; Kondo M; Matsushita M; Koshino I; Kon T; Sawada Y; Kasai Y
    Hokkaido Igaku Zasshi; 1980 Jan; 55(1):59-65. PubMed ID: 7409729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fulminant liver failure: clinical and experimental study.
    Slapak M
    Ann R Coll Surg Engl; 1975 Nov; 57(5):234-47. PubMed ID: 812415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.